Date: 09 May 2018
Story by HistoIndex
Fibrous septa have been regarded as an important parameter in fibrosis progression and regression, and are clinically important in tracking treatment efficacy.
With septa width and other similar parameters seen in chronic liver diseases like NASH, will the dual combination of this classification method and HistoIndex's multiphoton digital pathology system be potentially advantageous in quantifying fibrosis regression in NASH clinical trials?Read More
Date: 13 Mar 2018
A research collaboration in Singapore has discovered methods to efficiently generate pure liver cells from human stem cells, potentially leading to more effective ways of treating liver failure. This can greatly improve patient survival rates and alleviate the burden of liver failure.Read More
Date: 10 Mar 2018
Liver-transplant patients may have a similar prevalence of new-onset fatty liver disease to that of the general population, according to an Italian review and meta-analysis. The results raise concerns about graft failure and the need for retransplantation among patients.Read More
Date: 02 Mar 2018
Researchers in Japan investigated the relationship between alcohol intake and the cell changes seen in patients with NAFLD. They recently reported their findings in the journal PLoS ONE.Read More
Date: 01 Mar 2018
... Sophia had a pit in her stomach when they asked her to go for a liver biopsy as they had found abnormally high levels of certain enzymes in her blood. And she was diagnosed with the fourth stage of NASH and a notice of merely a month’s time to undergo a liver transplantation.Read More
Date: 19 Feb 2018
Cutting down on pasta, potatoes, and other such carbohydrate-rich foods has become a popular plan for weight loss. However, according to a new study, a carb-restricted diet may offer other health benefits.
foods rich in carbohydrates.
Date: 09 Feb 2018
The Innovate UK funding will be used to develop a unified data system that allows sharing of genomic (RNA-Seq)** and clinical information from patients with NASH, making it more accessible for further research. This system will be the first in the world for NASH, will lead to a deeper understanding of which tests and treatments are most effective for individual patients.Read More
Date: 07 Feb 2018
"The challenge is to ensure that those new technologies are nonetheless regarded as being complementary techniques to classical pathology, and are not considered a replacement on the basis of expertise in a single technology. Ultimately, it is the morphological diagnosis which has the biggest impact on predicting prognosis and response to treatment in cancer, and technologies such as wider sequencing refine this."Read More
Date: 05 Feb 2018
A growing body of research shows computer algorithms may soon outperform human pathologists in both accuracy and speed.
But rather than hand their diagnostic keys to machines, two pathology professors from Yale argue that artificial intelligence will emerge as a “powerful tool” that can accurately identify the drug or therapy that will be most beneficial to an individual patient’s disease.Read More